Azra is responsible for vaccines, brand & specialty pharmaceuticals, Rx technology as well as all pharmaceutical services programs. Bringing over 15 years of health care experience in retail, hospital, academic and specialty settings, Azra is recognized in the industry for her expertise and speaks at industry conferences on maximizing value and supply chain management for acute and non-acute settings.
Brian provides direction and support for advisory work related to ambulatory pharmacy. He helps health care organizations identify opportunities for implementing or expanding outpatient retail ambulatory, central fill and/or home delivery and specialty pharmacy operations. With over 25 years of experience in the health care industry, Brian's expertise spans multiple retail and ambulatory pharmacy market segments.
Dan has oversight for an expanded pharmacy program that links analytics, strategic sourcing and pharmacy networks into one team, while setting the strategic direction to ensure that Vizient members maximize value by utilizing the industry’s leading GPO pharmacy program.
Vizient Newsroom: Coalition Working to End Drug Shortages, Together - 2022
As performance improvement program director, pharmacy, Jim is primarily responsible for developing and leading performance improvement collaborative programs focusing on medication safety and adverse drug events.
Media: Drug Topics
Steven is responsible for providing education to member organizations and supporting their efforts on various clinical practice topics, including improving medication safety, mitigating the impact of drug shortages, benchmarking pharmacy costs for key drug classes, evaluating the expense of high-cost biologics and preparing for the future development of biosimilar medications.
Vizient Newsroom: Breaking it Down: Biologics and Biosimilars with Steven Lucio - 2022, Insights Learned from the Biosimilars Survey: Q&A with Steven Lucio - 2022
Published: Biosimilars and Biologics: Implementation and Monitoring in a Healthcare Setting 1st Edition
Mittal leads oversight for the industry-leading Novaplus® Enhanced Supply program, which gives Vizient members access to more than 100 million additional units of essential medications warehoused in the U.S. She leads a team that develops key strategic sourcing programs that focus on transparency, redundancy and commitment to support a resilient supply chain for essential medications, and to date, over a million doses of these critical medications have been accessed by health systems during a supply challenge.